Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells (Q28237966)

2

0 references

Chengjiang Gao

3

0 references

Hongtao Guo

4

0 references

Carlos Marroquin

5

0 references

Paul C Kuo

Journal of Biological Chemistry

6

0 references

language of work or name

English

0 references

publication date

14 July 2006

0 references

published in

0 references

volume

281

0 references

issue

28

0 references

page(s)

18973-82

0 references

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

21 January 2018

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

The role of Osteopontin in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

CD44 cell adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Receptor-ligand interaction between CD44 and osteopontin (Eta-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Highly metastatic variant of a mouse colon carcinoma cell line, LM17 and its response to GM-CSF gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

S-nitrosylation of heterogeneous nuclear ribonucleoprotein A/B regulates osteopontin transcription in endotoxin-stimulated murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Overexpression of osteopontin in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Osteopontin regulates multiple functions contributing to human colon cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

RETRACTED: JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Cloning and characterization of the human osteopontin gene and its promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Identification and preferential expression in thymic and bursal lymphocytes of a c-ets oncogene-encoded Mr 54,000 cytoplasmic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

The biology of the Ets1 proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Molecular biology of the Ets family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Ets proteins in biological control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Nomenclature for Runt-related (RUNX) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

RUNX: a trilogy of cancer genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Runx transcription factors and the developmental balance between cell proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

RUNX transcription factors as key targets of TGF-beta superfamily signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

The RUNX genes: gain or loss of function in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Expression of the ets-1 proto-oncogene in human colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Core-binding factors in haematopoiesis and leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Involvement of Ets transcription factors and targets in osteoblast differentiation and matrix mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Expression pattern, regulation, and biological role of runt domain transcription factor, run, in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Osteopontin and colon cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Osteopontin expression in a group of lymph node negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Co-expression of osteopontin and CD44v9 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Osteopontin expression in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an alpha helix

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

The Ets-1 transcription factor is required for the development of natural killer cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200

Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M511962200